🇺🇸 FDA
Patent

US 10238618

Compositions and methods for diagnosis and treatment of anemia

granted A61KA61K31/20A61K31/202

Quick answer

US patent 10238618 (Compositions and methods for diagnosis and treatment of anemia) held by United States of America as represented by the Secretary of the Air Force expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/20, A61K31/202, A61P, A61P7/06